Cumberland Pharmaceuticals Inc.
CPIX
$3.40
$0.144.29%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 71.75% | 61.08% | -3.19% | -348.15% | -481.30% |
Total Depreciation and Amortization | 1.98% | 2.52% | 4.73% | 14.16% | 14.56% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -144.92% | -127.30% | -174.65% | 192.62% | 193.32% |
Change in Net Operating Assets | 165.40% | -9.39% | -72.10% | -78.87% | -78.61% |
Cash from Operations | 1,095.17% | 0.88% | -110.05% | -116.99% | -107.09% |
Capital Expenditure | 39.04% | 66.37% | 76.36% | -42.73% | -28.28% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -425.62% | -559.64% | -29.21% | 149.36% | 285.43% |
Cash from Investing | -1,388.43% | -10,692.38% | 154.63% | 134.27% | 126.16% |
Total Debt Issued | -56.00% | -20.26% | 22.28% | 35.74% | 25.33% |
Total Debt Repaid | 20.83% | -11.23% | -3.17% | -7.97% | 3.41% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 41.71% | 27.94% | 21.82% | 9.67% | -25.67% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 35.88% | 34.42% | 47.49% | 24.67% | 27.73% |
Cash from Financing | -2,847.24% | -140.44% | 102.65% | 101.01% | 97.38% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -36.90% | -259.09% | 75.12% | -0.92% | -2,907.69% |